25Jan

A Valuable New Information Resource for Faecal Immunochemical Testing (FIT) for Bowel Cancer Detection

www.faecal-immunochemical-test.co.uk is a dedicated new website, developed by Alpha Laboratories Ltd., to raise awareness amongst clinicians, laboratories, patients and the public, about advances in the detection of colorectal cancer using the faecal immunochemical test (FIT). You can find out all about why FIT is being adopted by the bowel cancer screening programmes and is also now recommended by NICE DG30, to guide referral for colorectal cancer in primary care for symptomatic patients.

This new resource provides a repository of information for all those involved in FIT. Experiential case studies, plus videos of presentations, provide access to expertise from key opinion leaders in the field. With pages tailored to each part of the patient pathway, an extensive list of literature, publications, resources, related news and events that are regularly updated, it is the number one resource for FIT in the UK and Eire.
 
www.faecal-immunochemical-test.co.uk also offers useful information on products and solutions necessary to provide a FIT service. With Alpha Laboratories’ Bowel Cancer Specialists on hand to help develop your specific programme it is the ‘go to’ place for advice from the experts, whose knowledge has been gained from many years’ experience in faecal occult blood testing and a long association with the NHS bowel cancer screening programmes. 
FIT is now an established diagnostic test that identifies the presence of minute quantities of haemoglobin (blood) in the stool, known as faecal occult blood (FOB), which can be an early sign of colorectal cancer. FIT uses antibodies specific to human haemoglobin so is more sensitive and has a greater specificity than the previous qualitative guaiac based methods.
 
FIT is being adopted by the National Bowel Cancer Screening programmes and is expected to improve uptake since the sampling method is easier, more hygienic and more acceptable to people invited for screening. The automated FIT assay benefits clinicians and laboratories too; with rapid turn-around, quantitative results, and simple processing.
 
Since the announcement in July 2017 by the National Institute of Health and Care Excellence (NICE) regarding FIT, the interest in the test has increased dramatically. NICE Guidance DG30 recommends “Quantitative faecal immunochemical tests to guide referral for colorectal cancer in primary care”. It also concludes that, “FIT should be used to triage for referral to secondary care, people whose symptoms suggest colorectal cancer, but in whom a definitive diagnosis of cancer is unlikely.”
 
Please visit www.faecal-immunochemical-test.co.uk for further information or contact Alpha Laboratories on 0800 38 77 32 or email marketing@alphalabs.co.uk
 
About Alpha Laboratories Ltd
Established in 1975, Alpha Laboratories’ ongoing mission is to continually find new ways to help science improve people’s lives through its evolving specialist diagnostic and laboratory supplies.
The top quality range of laboratory consumables includes Pastettes®, pipette tips, pipettes, general liquid handling, microtubes, racks, PCR consumables and UN3373 compliant sample transport packaging. The research market is supported with an extensive range of antibodies and reagents for numerous disciplines. The diagnostics portfolio offers specialist assays, controls, reagents and instruments used in blood grouping, clinical chemistry, haematology, haemostasis, immunology and rapid test specialities. Specialist areas include bowel cancer screening, inflammatory bowel disease testing and monitoring and rapid sepsis species ID.

The company is BS EN ISO 9001:2008 and 14001:2004 accredited and certified for Investors in People and Workplace Conditions Assessment. 

Related

Member Press Release - Life Science Group receives ISO 13485 accreditation

Life Science Group receives ISO 13485 accreditation. Life Science Group (LSG), one of the UK...

Read More >

Press Release: Life Science Group shortlisted as a finalist for the Medilink Midlands Business Awards 2022

Life Science Group (LSG) has been shortlisted for a prestigious award which recognises and promotes ...

Read More >

Protect Your Samples from Acidification When Shipped On Dry Ice

The new ProtectR® tubes, now available from Alpha Laboratories, have the only container closure syst...

Read More >

Improved Nucleic Acid Isolation

New QuickGene Range for DNA & RNA Extraction- Now with Automated Option

Read More >

EKF Diagnostics publishes ‘Diabetes and HbA1c testing’ guide

Cardiff, UK – 17th July 2017 – EKF Diagnostics, the global in vitro diagnostics company, has publi...

Read More >

Novodiag® launch, a new diagnostic solution for infectious diseases.

Espoo, Finland, January 3rd, 2018 - Mobidiag, a Finnish molecular diagnostics company, launches Novo...

Read More >